These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24345589)

  • 21. Is the molecular clock ticking differently in bipolar disorder? Methylation analysis of the clock gene ARNTL.
    Bengesser SA; Reininghaus EZ; Lackner N; Birner A; Fellendorf FT; Platzer M; Kainzbauer N; Tropper B; Hörmanseder C; Queissner R; Kapfhammer HP; Wallner-Liebmann SJ; Fuchs R; Petek E; Windpassinger C; Schnalzenberger M; Reininghaus B; Evert B; Waha A
    World J Biol Psychiatry; 2018; 19(sup2):S21-S29. PubMed ID: 27739341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The protective effect of melatonin against brain oxidative stress and hyperlocomotion in a rat model of mania induced by ouabain.
    Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR
    Behav Brain Res; 2014 Sep; 271():316-24. PubMed ID: 24959861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced antioxidant defense systems in schizophrenia and bipolar I disorder.
    Raffa M; Barhoumi S; Atig F; Fendri C; Kerkeni A; Mechri A
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Dec; 39(2):371-5. PubMed ID: 22841966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects.
    Machado-Vieira R; Andreazza AC; Viale CI; Zanatto V; Cereser V; da Silva Vargas R; Kapczinski F; Portela LV; Souza DO; Salvador M; Gentil V
    Neurosci Lett; 2007 Jun; 421(1):33-6. PubMed ID: 17548157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effect of Organic Lithium Salts on Plasma 8-Hydroxy-2'-Deoxyguanosine in Bipolar Patients
    Valentina P; Ekaterina Y; Nikolay B; Evgenii P
    Psychopharmacol Bull; 2020 Mar; 50(1):19-27. PubMed ID: 32214518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of lithium alone or in combination with haloperidol on oxidative stress parameters and cell viability in SH-SY5Y cell culture.
    Gawlik-Kotelnicka O; Mielicki W; Rabe-Jabłońska J; Lazarek J; Strzelecki D
    Acta Neuropsychiatr; 2016 Feb; 28(1):38-44. PubMed ID: 26286703
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct lithium-induced gene expression effects in lymphoblastoid cell lines from patients with bipolar disorder.
    Fries GR; Colpo GD; Monroy-Jaramillo N; Zhao J; Zhao Z; Arnold JG; Bowden CL; Walss-Bass C
    Eur Neuropsychopharmacol; 2017 Nov; 27(11):1110-1119. PubMed ID: 28939162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of lithium therapy on Na+-K+-ATPase activity and lipid peroxidation in bipolar disorder.
    Banerjee U; Dasgupta A; Rout JK; Singh OP
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Apr; 37(1):56-61. PubMed ID: 22230647
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oxidative imbalance in bipolar disorder subtypes: a comparative study.
    Yumru M; Savas HA; Kalenderoglu A; Bulut M; Celik H; Erel O
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):1070-4. PubMed ID: 19527764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium decreases VEGF mRNA expression in leukocytes of healthy subjects and patients with bipolar disorder.
    Kikuchi K; Iga J; Tayoshi S; Nakataki M; Watanabe S; Numata S; Ohmori T
    Hum Psychopharmacol; 2011; 26(4-5):358-63. PubMed ID: 21721043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A-I as a candidate serum marker for the response to lithium treatment in bipolar disorder.
    Sussulini A; Dihazi H; Banzato CE; Arruda MA; Stühmer W; Ehrenreich H; Jahn O; Kratzin HD
    Proteomics; 2011 Jan; 11(2):261-9. PubMed ID: 21204253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased oxidative stress in the mitochondria isolated from lymphocytes of bipolar disorder patients during depressive episodes.
    Valvassori SS; Bavaresco DV; Feier G; Cechinel-Recco K; Steckert AV; Varela RB; Borges C; Carvalho-Silva M; Gomes LM; Streck EL; Quevedo J
    Psychiatry Res; 2018 Jun; 264():192-201. PubMed ID: 29653348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An imbalance in the production of IL-1beta and IL-6 by monocytes of bipolar patients: restoration by lithium treatment.
    Knijff EM; Breunis MN; Kupka RW; de Wit HJ; Ruwhof C; Akkerhuis GW; Nolen WA; Drexhage HA
    Bipolar Disord; 2007 Nov; 9(7):743-53. PubMed ID: 17988365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of in vivo lithium treatment on (-)isoproterenol-stimulated cAMP accumulation in lymphocytes of healthy subjects and patients with affective psychoses.
    Lonati-Galligani M; Emrich HM; Raptis C; Pirke KM
    Pharmacopsychiatry; 1989 Nov; 22(6):241-5. PubMed ID: 2559417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased oxidative stress and DNA damage in bipolar disorder: a twin-case report.
    Frey BN; Andreazza AC; Kunz M; Gomes FA; Quevedo J; Salvador M; Gonçalves CA; Kapczinski F
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):283-5. PubMed ID: 16859818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The anti-aging effects of lithium in lymphoblastoid cell lines from patients with bipolar disorder and controls.
    Fries GR; Zamzow MJ; Colpo GD; Monroy-Jaramillo N; Quevedo J; Arnold JG; Bowden CL; Walss-Bass C
    J Psychiatr Res; 2020 Sep; 128():38-42. PubMed ID: 32516629
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for association of an ACCN1 gene variant with response to lithium treatment in Sardinian patients with bipolar disorder.
    Squassina A; Manchia M; Borg J; Congiu D; Costa M; Georgitsi M; Chillotti C; Ardau R; Mitropoulos K; Severino G; Del Zompo M; Patrinos GP
    Pharmacogenomics; 2011 Nov; 12(11):1559-69. PubMed ID: 21961650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum S100B and antioxidant enzymes in bipolar patients.
    Andreazza AC; Cassini C; Rosa AR; Leite MC; de Almeida LM; Nardin P; Cunha AB; Ceresér KM; Santin A; Gottfried C; Salvador M; Kapczinski F; Gonçalves CA
    J Psychiatr Res; 2007 Sep; 41(6):523-9. PubMed ID: 16956621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA methylation, insulin resistance and second-generation antipsychotics in bipolar disorder.
    Burghardt KJ; Goodrich JM; Dolinoy DC; Ellingrod VL
    Epigenomics; 2015; 7(3):343-52. PubMed ID: 26077424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular models to study bipolar disorder: A systematic review.
    Viswanath B; Jose SP; Squassina A; Thirthalli J; Purushottam M; Mukherjee O; Vladimirov V; Patrinos GP; Del Zompo M; Jain S
    J Affect Disord; 2015 Sep; 184():36-50. PubMed ID: 26070045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.